Clinical Hepatocellular Carcinoma

The molecular targets of interest have expanded from angiogenesis to cancer cell-directed oncogenic signaling pathways for advanced HCC treatment. The feasibility of combining locoregional therapies and targeted agents, and the use of novel agents after curative treatments are currently under active investigation. Finally, the therapeutic strategy has shifted from monotherapy to combination targeted therapy.

  • Partial Hepatectomy
  • Clinical Analysis of Cells
  • Intra - arterial Chemotherapy
  • AFP Blood Testing

Related Conference of Clinical Hepatocellular Carcinoma

May 21-22, 2026

17th International Conference on Liver Diseases & Hepatology

Aix-en-Provence, France
June 18-19, 2026

9th International Congress on Viral Hepatitis

Paris, France
August 03-04, 2026

21st Euro-Global Gastroenterology Conference

London, UK
September 29-30, 2026

7th Global Summit on Earth Science and Climate Change

Aix-en-Provence, France

Clinical Hepatocellular Carcinoma Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in